Carnosine protects stimulus-secretion coupling through prevention of protein carbonyl adduction events in cells under metabolic stress

Free Radic Biol Med. 2021 Nov 1:175:65-79. doi: 10.1016/j.freeradbiomed.2021.08.233. Epub 2021 Aug 27.

Abstract

Type 2 diabetes is characterised by failure to control glucose homeostasis, with numerous diabetic complications attributable to the resulting exposure of cells and tissues to chronic elevated concentrations of glucose and fatty acids. This, in part, results from formation of advanced glycation and advanced lipidation end-products that are able to modify protein, lipid, or DNA structure, and disrupt normal cellular function. Herein we used mass spectrometry to identify proteins modified by two such adduction events in serum of individuals with obesity, type 2 diabetes, and gestational diabetes, along with similar analyses of human and mouse skeletal muscle cells and mouse pancreatic islets exposed to glucolipotoxic stress. We also report that carnosine, a histidine containing dipeptide, prevented 65-90% of 4-hydroxynonenal and 3-nitrotyrosine adduction events, and that this in turn preserved mitochondrial function and protected stimulus-secretion coupling in cells exposed to metabolic stress. Carnosine therefore offers significant therapeutic potential against metabolic diseases.

Keywords: GLUT4 translocation; Gestational diabetes; Glucolipotoxicity; Obesity; Reactive species scavenging; Type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carnosine* / pharmacology
  • Diabetes Complications*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glycation End Products, Advanced / metabolism
  • Mice
  • Oxidative Stress
  • Protein Carbonylation

Substances

  • Glycation End Products, Advanced
  • Carnosine